13 Feb 2024
Amber Enterprises
BOB Capital Markets Ltd.
Reco
Target
8162.50
3200.00
3603.75
(126.50%)
Target met
Sell
Broker Report
AMBER: Persistent near-term challenges; cut to SELL. CPI and IIP: Still some pain points on inflation. Credit Composition: Study on personal loans. HMCL: Healthy quarter but positives priced in. TMX: Improving order outlook; maintain HOLD. BANDHAN: Recovery on track. IGL: Legacy UP, new GAs can offset slowdown, reiterate BUY. ZYWL: Seasonally weak quarter
12 Feb 2024
Brigade Enterprises
Geojit BNP Paribas
Target
905.10
845.00
973.75
(-7.05%)
Target met
Sell
12 Feb 2024
Escorts Kubota
BOB Capital Markets Ltd.
3543.70
2389.00
2815.90
(25.85%)
Sell
Broker Report
LICI: Solid quarter; valuations overdone cut to HOLD. ALKEM: Good quarter; cut to SELL on stretched valuations. Monthly Chartbook: Fiscal consolidation to hold key. PWGR: In-line quarter, FY25 capex hiked; maintain BUY. TATACONS: Strong run continues. DIVI: Healthy margin recovery, heady valuations. TPW: Dull quarter; high valuations maintain HOLD. ESCORTS: Weakness persists - maintain SELL. TRCL: Tepid quarter, high capex overhang retain SELL. Metals & Mining: Ferrous read-across: Steel recovery in CY24 - ArcelorMittal
12 Feb 2024
Divi's Laboratories
BOB Capital Markets Ltd.
5689.50
3000.00
3740.15
(52.12%)
Sell
Broker Report
LICI: Solid quarter; valuations overdone cut to HOLD. ALKEM: Good quarter; cut to SELL on stretched valuations. Monthly Chartbook: Fiscal consolidation to hold key. PWGR: In-line quarter, FY25 capex hiked; maintain BUY. TATACONS: Strong run continues. DIVI: Healthy margin recovery, heady valuations. TPW: Dull quarter; high valuations maintain HOLD. ESCORTS: Weakness persists - maintain SELL. TRCL: Tepid quarter, high capex overhang retain SELL. Metals & Mining: Ferrous read-across: Steel recovery in CY24 - ArcelorMittal
11 Feb 2024
Divi's Laboratories
Prabhudas Lilladhar
Target
5689.50
3150.00
3652.30
(55.78%)
Sell
11 Feb 2024
Aarti Industries
Prabhudas Lilladhar
Reco
Target
374.60
599.00
663.35
(-43.53%)
Target met
Sell
10 Feb 2024
Divi's Laboratories
BOB Capital Markets Ltd.
Reco
Target
5689.50
3000.00
3652.30
(55.78%)
Sell
Broker Report
Q3 revenue grew 9% YoY on 25% rise in custom synthesis business; API and nutraceuticals stayed soft
10 Feb 2024
Alkem Laboratories
BOB Capital Markets Ltd.
Reco
Target
5433.00
4800.00
5327.90
(1.97%)
Target met
Sell
Broker Report
Revenue grew 9% YoY in Q3 backed by strong India and ROW growth that offset lower US business
09 Feb 2024
The Ramco Cements
BOB Capital Markets Ltd.
Target
1001.60
728.00
901.75
(11.07%)
Target met
Sell
Broker Report
Q3 revenue growth muted at 6% YoY due to poor demand; pricing pressure dampens realisations
09 Feb 2024
Escorts Kubota
BOB Capital Markets Ltd.
Target
3543.70
2389.00
2807.25
(26.23%)
Sell
Broker Report
Q3 tractor volumes dipped 7% YoY, with loss of domestic share as fall was higher than industry decline